“This publication validates our belief that precision medicine should be measured, not marketed,” said Katy Whalen, ...
Please provide your email address to receive an email when new articles are posted on . Racial and ethnic minority populations remain underrepresented in many precision oncology trials relative to ...
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Last week the Edinburgh Cancer Centre begun treating prostate cancer patients within the framework of the so-called Precision Study. Patients receive ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, genetic blood disorders and autoimmune diseases, ...
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A pair of West Coast health firms have ...
Experts begin to unlock the commercial potential of precision medicine with the first ever side by side economic analysis Experts begin to unlock the commercial potential of precision medicine with ...
On Tuesday, Praxis Precision Medicines Inc. (NASDAQ:PRAX) released topline results for its EMBOLD Phase 2 proof-of-concept study evaluating relutrigine in SCN2A and SCN8A developmental and epileptic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results